Note 5 – Marketable Securities

On October 15, 2024, the Company purchased $5,011,913 in certain publicly listed marketable securities through an open market transaction. The investment was initially recorded at cost and subsequently measured at fair value with the changes in fair value recorded in other income (expenses), net in the consolidated statements of operations. For the years ended December 31, 2025 and 2024, the Company recorded an increase (decrease) in fair value of $841,392 and ($536,116), respectively.

The following is a roll forward of the Company’s marketable securities balance during the year ended December 31, 2025:

Balance as of January 1, 2025	$	3,483,211
Proceeds from sale of marketable securities		(3,056,668	)
Net realized/unrealized gain on marketable securities		841,392
Foreign currency transaction adjustment		66,784
Balance as of December 31, 2025	$	1,334,719